Nuclear receptor is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-05-18. Where a claim depends on a specific study, the study is described rather than over-claimed.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA as a metabolic modulator. |
| Approved medical use | None in major jurisdictions | Not a registered drug. |
| Common test matrix | Urine | Most anti-doping samples use urine. |
| Typical detection method | LC-MS/MS | Detects parent compound and metabolites. |
| Reference standard storage | -20 °C, desiccated | Typical for analytical standards. |
Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.
Handling and quality assessment of cardarine reference material follow general laboratory practices for poorly characterized compounds. It typically appears as a white to off-white powder and is sparingly soluble in water but soluble in organic solvents such as dimethyl sulfoxide and ethanol. Storage recommendations usually specify a cool, dry, dark place, with long-term storage at low temperature and desiccation. Purity may be checked by high-performance liquid chromatography with ultraviolet detection, while identity is confirmed by mass spectrometry and nuclear magnetic resonance. No pharmacopeial monograph exists, so reported purity and stability depend on the supplier’s methods.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
1947 - the Ciba Award from the Endocrine Society 1951 - the Award of American Chemical Society 1955 - the Amory Prize of American Academy of Arts and Sciences 1962 - the first Albert Lasker Award for Basic Medical Research 1970 - the Scientific Achievement Award from American Medical Association 1971 - the National Award of the American Cancer Society 1972 - the Nicholas Andry Award from the Association of Bone and Joint Surgeons 1977 - the Lewis Price of the American Philosophical Society 1979 - the William H. Nichols Medal of the American Chemical Society 1981 - the Koch Award of the Endocrine Society 1987 - the Alan E. Pierce Award (now R. Bruce Merrifield Award) from American Peptide Society Li was elected to the following academies:
== Research areas == RCB engages in contemporary research at the interface of disciplines constituting biotechnology in its broadest definition. Research programmes aim to integrate science, engineering, medicine and agriculture in biotechnology and emphasize on their relevance to the regional societies. A broad range of research areas planned include:
Machine vision systems often require bright and homogeneous illumination, so features of interest are easier to process. LEDs are often used. Barcode scanners are the most common example of machine vision applications, and many of those scanners use red LEDs instead of lasers. Optical computer mice use LEDs as a light source for the miniature camera within the mouse. LEDs are useful for machine vision because they provide a compact, reliable source of light. LED lamps can be turned on and off to suit the needs of the vision system, and the shape of the beam produced can be tailored to match the system's requirements.
) increases as [S] increases. However, as [S] gets higher, the enzyme becomes saturated with substrate and the initial rate reaches Vmax, the enzyme's maximum rate. In the Michaelis–Menten kinetic model of a single-substrate reaction there is an initial bimolecular reaction between the enzyme E and substrate S to form the enzyme–substrate complex ES. The rate of enzymatic reaction increases with the increase of the substrate concentration up to a certain level called Vmax; at Vmax, increase in substrate concentration does not cause any increase in reaction rate as there is no more enzyme (E) available for reacting with substrate (S). Here, the rate of reaction becomes dependent on the ES complex and the reaction becomes a unimolecular reaction with an order of zero. Though the enzymatic mechanism for the unimolecular reaction
During his tenure with the X-Men, Wolverine becomes a mentor for Kitty Pryde and later on Jubilee. Logan again encounters Jean, who has been resurrected and re-joins the X-Men, leading to resumption of Logan's rivalry with Cyclops. He is able to recall some of the trauma he received from the Weapon X program and tries to investigate his past, although his memories remain unreliable because of brainwashing and false memory implants. He meets Maverick, another former participant in the Weapon X project, and discovers that he had previously worked together with Sabretooth in Team X. During a conflict, the supervillain Magneto forcibly removes the adamantium from Wolverine's skeleton. This massive trauma causes his healing factor to burn out and leads to the discovery that his claws are actually bone. Wolverine leaves the X-Men for a time, embarking on a series of adventures during which his healing factor returns. After his return to the X-Men, Cable's son Genesis kidnaps Wolverine and attempts to re-bond adamantium to his skeleton. This is unsuccessful and causes Wolverine's mutation to accelerate out of control. He degenerates physically and mentally into a more primitive, bestial state. Elektra helps him to recover his humanity. Eventually, the villain Apocalypse captures Wolverine, brainwashes him into becoming the Horseman of Death, and successfully re-bonds adamantium to his skeleton. Wolverine overcomes Apocalypse's programming and returns to the X-Men.
Sources: en.wikipedia.org
Regulation of gene expression is the control of the amount and timing of appearance of the functional product of a gene. Control of expression is vital to allow a cell to produce the gene products it needs when it needs them; in turn, this gives cells the flexibility to adapt to a variable environment, external signals, damage to the cell, and other stimuli. More generally, gene regulation gives the cell control over all structure and function, and is the basis for cellular differentiation, morphogenesis and the versatility and adaptability of any organism. Numerous terms are used to describe types of genes depending on how they are regulated; these include:
The Economic Times cited surveys showing "broad negative sentiment" about the economy, and Harris being "relentlessly hammered" by Trump during campaigns about this. The Economic Times cited University of Richmond School of Law professor Carl Tobias' appraisal of Trump's stance on immigration winning over Harris', and mentioned how Trump had increased his support from Hispanics, especially near the Mexican–American border and in areas impacted by recent immigration. Harris campaigning at multiple events with former Republican representative Liz Cheney has been suggested as a contributing factor as to why she lost. Los Angeles Times's Noah Bierman felt Harris could not overcome being the "turn the page" candidate, and cited former president Barack Obama's lead strategist David Axelrod, who said: "If you're the vice president of an administration people want to fire, you're way behind the eight-ball to start." Bierman wrote that besides criminal context, Trump "never followed a script, scoffed at the rules and spoke directly to the economic and cultural anxieties of the country". In The New York Times, Timothy Shenk argued that Democrats failed to articulate a vision for the future other than being against Trump and did not lean into a message of economic populism that polled best with swing voters, but also that the election looked more like a rejection of Biden than the embrace of Trump.
=== 2014: further expansion === In 2014 a $42.5 million project to expand and improve the VCA was announced. Supported chiefly by the Victorian Government and the University of Melbourne, the initiative aimed to both "ensure that the VCA maintains its high standards in arts training and research" and "open up the campus to the wider community". A portion of the funding was to be spent acquiring and redeveloping the nearby Dodds Street Stables of the Victoria Police mounted branch. Major contributors included the Myer Foundation, the Ian Potter Foundation, and Martyn and Louise Myer.
Nautiluses are the only extant cephalopods with a true external shell. However, all molluscan shells are formed from the ectoderm (outer layer of the embryo); in cuttlefish (Sepia spp.), for example, an invagination of the ectoderm forms during the embryonic period, resulting in a shell (cuttlebone) that is internal in the adult. The same is true of the chitinous gladius of squid and octopuses. Cirrate octopods have arch-shaped cartilaginous fin supports, which are sometimes referred to as a "shell vestige" or "gladius". The Incirrina have either a pair of rod-shaped stylets or no vestige of an internal shell, and some squid also lack a gladius. The shelled coleoids do not form a clade or even a paraphyletic group. The Spirula shell begins as an organic structure, and is then very rapidly mineralized. Shells that are "lost" may be lost by resorption of the calcium carbonate component. Females of the octopus genus Argonauta secrete a specialized paper-thin egg case in which they reside, and this is popularly regarded as a "shell", although it is not attached to the body of the animal and has a separate evolutionary origin. The largest group of shelled cephalopods, the ammonites, are extinct, but their shells are very common as fossils. Ammonites thrived during the Paleozoic and Mesozoic eras. Their distinctive, spiral-shaped shells are found in sedimentary rocks worldwide and subsequently in many human creations.
Sources: en.wikipedia.org
Legal status varies by country, but cardarine is not approved as a medicine in major jurisdictions. It is often sold as a research chemical, a category that may not be lawful for human use. Buyers should check local laws and product labels carefully.
Anti-doping laboratories use LC-MS/MS to detect GW501516 and its metabolites, usually in urine. The method can identify the parent compound at low concentrations. Detection windows vary with dose and individual factors.
No, cardarine has no approved medical uses in major jurisdictions. Early research explored metabolic conditions, but those programs were discontinued. It is not a registered treatment for any disease.
Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.